Elli Peselev

Array ( [id] => 7687572 [patent_doc_number] => 20090176719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING PERIORAL DERMATITIS' [patent_app_type] => utility [patent_app_number] => 12/349671 [patent_app_country] => US [patent_app_date] => 2009-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3879 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176719.pdf [firstpage_image] =>[orig_patent_app_number] => 12349671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8538350 [patent_doc_number] => 08314071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-20 [patent_title] => 'Bioactive molecules from co-cultivation of microbes' [patent_app_type] => utility [patent_app_number] => 12/599730 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12302 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12599730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7801162 [patent_doc_number] => 08129434 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => 'Benzylphenyl cyclohexane derivatives and methods of use' [patent_app_type] => utility [patent_app_number] => 12/333190 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 23684 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/129/08129434.pdf [firstpage_image] =>[orig_patent_app_number] => 12333190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422940 [patent_doc_number] => 20090149395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'NOVEL MACROCYCLIC POLYENE LACTAMS' [patent_app_type] => utility [patent_app_number] => 12/331594 [patent_app_country] => US [patent_app_date] => 2008-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16147 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149395.pdf [firstpage_image] =>[orig_patent_app_number] => 12331594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9749842 [patent_doc_number] => 08841319 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'Use of 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide derivatives in leukemia management' [patent_app_type] => utility [patent_app_number] => 12/746630 [patent_app_country] => US [patent_app_date] => 2008-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9824 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12746630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527438 [patent_doc_number] => 08044030 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Antibiotic macrocycle compounds and methods of manufacture and use thereof' [patent_app_type] => utility [patent_app_number] => 12/324907 [patent_app_country] => US [patent_app_date] => 2008-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9679 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/044/08044030.pdf [firstpage_image] =>[orig_patent_app_number] => 12324907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8701560 [patent_doc_number] => 08394782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-12 [patent_title] => 'Polysaccharide gel formulation having increased longevity' [patent_app_type] => utility [patent_app_number] => 12/276167 [patent_app_country] => US [patent_app_date] => 2008-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 6147 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12276167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279211 [patent_doc_number] => 20090131343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'USE OF BRIDGED MACROLIDES OR TYLOSIN DERIVATIVES IN TREATING INFLAMMATORY BOWEL DISEASES' [patent_app_type] => utility [patent_app_number] => 12/270967 [patent_app_country] => US [patent_app_date] => 2008-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11429 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131343.pdf [firstpage_image] =>[orig_patent_app_number] => 12270967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7687573 [patent_doc_number] => 20090176718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Berry Preparations For Treatment Of Diabetes And Metabolic Syndrome' [patent_app_type] => utility [patent_app_number] => 12/263297 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24477 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176718.pdf [firstpage_image] =>[orig_patent_app_number] => 12263297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4644443 [patent_doc_number] => 08022048 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => 'Method of treating vitamin B12 deficiency' [patent_app_type] => utility [patent_app_number] => 12/262677 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3188 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/022/08022048.pdf [firstpage_image] =>[orig_patent_app_number] => 12262677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 123003 [patent_doc_number] => 07704960 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Macrolide compounds endowed with antiinflammatory activity' [patent_app_type] => utility [patent_app_number] => 12/259335 [patent_app_country] => US [patent_app_date] => 2008-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15577 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/704/07704960.pdf [firstpage_image] =>[orig_patent_app_number] => 12259335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6614755 [patent_doc_number] => 20100099637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'USE OF CYCLOARTANE COMPOUNDS FOR TREATING ARTHRITIS' [patent_app_type] => utility [patent_app_number] => 12/253779 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8250 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099637.pdf [firstpage_image] =>[orig_patent_app_number] => 12253779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9703890 [patent_doc_number] => 08828952 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Sulfated oligosaccharide derivatives' [patent_app_type] => utility [patent_app_number] => 12/738552 [patent_app_country] => US [patent_app_date] => 2008-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 92 [patent_figures_cnt] => 95 [patent_no_of_words] => 48120 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12738552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585993 [patent_doc_number] => 20090105195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'COMPOSITION COMPRISING MICROBICIDAL ACTIVE INGREDIENTS' [patent_app_type] => utility [patent_app_number] => 12/252971 [patent_app_country] => US [patent_app_date] => 2008-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14127 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105195.pdf [firstpage_image] =>[orig_patent_app_number] => 12252971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5930272 [patent_doc_number] => 20110040078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'PROCESS FOR THE PRODUCTION OF TELITHROMYCIN' [patent_app_type] => utility [patent_app_number] => 12/739194 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6222 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20110040078.pdf [firstpage_image] =>[orig_patent_app_number] => 12739194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5285671 [patent_doc_number] => 20090099346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'THERMALLY STABLE CRYSTALLINE EPIRUBICIN HYDROCHLORIDE' [patent_app_type] => utility [patent_app_number] => 12/245755 [patent_app_country] => US [patent_app_date] => 2008-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 3203 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099346.pdf [firstpage_image] =>[orig_patent_app_number] => 12245755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519817 [patent_doc_number] => 20100261873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'GLYCOPROTEINS AND GLYCOSYLATED CELLS AND A METHOD FOR THE PREPARATION OF THE SAME' [patent_app_type] => utility [patent_app_number] => 12/733672 [patent_app_country] => US [patent_app_date] => 2008-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10374 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261873.pdf [firstpage_image] =>[orig_patent_app_number] => 12733672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515403 [patent_doc_number] => 20090215710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'CARBOHYDRATE BASED TOLL-LIKE RECEPTOR (TLR) ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/236358 [patent_app_country] => US [patent_app_date] => 2008-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 20688 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215710.pdf [firstpage_image] =>[orig_patent_app_number] => 12236358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5360558 [patent_doc_number] => 20090035352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'Drug Delivery Particle' [patent_app_type] => utility [patent_app_number] => 12/235978 [patent_app_country] => US [patent_app_date] => 2008-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8332 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20090035352.pdf [firstpage_image] =>[orig_patent_app_number] => 12235978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495874 [patent_doc_number] => 20100286084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Oligomer-Nucleoside Phosphate Conjugates' [patent_app_type] => utility [patent_app_number] => 12/676128 [patent_app_country] => US [patent_app_date] => 2008-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23972 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286084.pdf [firstpage_image] =>[orig_patent_app_number] => 12676128 [rel_patent_id] =>[rel_patent_doc_number] =>)